Neil Woodward
Last active: 6/26/2018

Profile

My research focuses on the neural basis of psychiatric disorders, including schizophrenia, bipolar disorder, and autism. My lab uses a variety of approaches, including structural and functional neuroimaging and psychological testing. For more details, visit our lab at www.woodwardlab.com. Neil Woodward¿¿¿s background includes training in clinical neuropsychology, neuroimaging, and neuropsychopharmacology. Neil received a Ph.D. in clinical psychology from Vanderbilt University in 2007 following completion of an accredited internship in clinical neuropsychology at the Edmonton Consortium Clinical Psychology Residency program. Neil has been an Assistant Professor in the Department of Psychiatry and a member of the Psychiatric Neuroimaging Program at Vanderbilt since July 2009.

Publications

The following timeline graph is generated from all co-authored publications.

Featured publications are shown below:

  1. Mapping Thalamocortical Functional Connectivity in Chronic and Early Stages of Psychotic Disorders. Woodward ND, Heckers S (2016) Biol Psychiatry 79(12): 1016-25
    › Primary publication · 26248537 (PubMed) · PMC4698230 (PubMed Central)
  2. Increased Amplitude of Low Frequency Fluctuations but Normal Hippocampal-Default Mode Network Connectivity in Schizophrenia. McHugo M, Rogers BP, Talati P, Woodward ND, Heckers S (2015) Front Psychiatry : 92
    › Primary publication · 26157396 (PubMed) · PMC4478381 (PubMed Central)
  3. Resting-State Functional Connectivity in Psychiatric Disorders. Woodward ND, Cascio CJ (2015) JAMA Psychiatry 72(8): 743-4
    › Primary publication · 26061674 (PubMed) · PMC4693599 (PubMed Central)
  4. Schizotypy and clinical symptoms, cognitive function, and quality of life in individuals with a psychotic disorder. Brosey E, Woodward ND (2015) Schizophr Res 166(1-3): 92-7
    › Primary publication · 26002072 (PubMed)
  5. Brain Structure in Neuropsychologically Defined Subgroups of Schizophrenia and Psychotic Bipolar Disorder. Woodward ND, Heckers S (2015) Schizophr Bull 41(6): 1349-59
    › Primary publication · 25904725 (PubMed) · PMC4601708 (PubMed Central)
  6. The course of neuropsychological impairment and brain structure abnormalities in psychotic disorders. Woodward ND (2016) Neurosci Res : 39-46
    › Primary publication · 25152315 (PubMed)
  7. Processing speed impairment in schizophrenia is mediated by white matter integrity. Karbasforoushan H, Duffy B, Blackford JU, Woodward ND (2015) Psychol Med 45(1): 109-20
    › Primary publication · 25066842 (PubMed) · PMC5297385 (PubMed Central)
  8. Response selection impairment in schizophrenia transcends sensory and motor modalities. Woodward ND, Duffy B, Karbasforoushan H (2014) Schizophr Res 152(2-3): 446-9
    › Primary publication · 24361304 (PubMed) · PMC3925400 (PubMed Central)
  9. Prefrontal cortex activity during response selection predicts processing speed impairment in schizophrenia. Woodward ND, Duffy B, Karbasforoushan H (2013) J Int Neuropsychol Soc 19(7): 782-91
    › Primary publication · 23816240 (PubMed) · PMC3910268 (PubMed Central)
  10. Resting-state networks in schizophrenia. Karbasforoushan H, Woodward ND (2012) Curr Top Med Chem 12(21): 2404-14
    › Primary publication · 23279179 (PubMed)
  11. A thalamocorticostriatal dopamine network for psychostimulant-enhanced human cognitive flexibility. Samanez-Larkin GR, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Arrington CM, Baldwin RM, Smith CE, Treadway MT, Kessler RM, Zald DH (2013) Biol Psychiatry 74(2): 99-105
    › Primary publication · 23273721 (PubMed) · PMC3615042 (PubMed Central)
  12. Reduced gray matter volume in psychotic disorder patients with a history of childhood sexual abuse. Sheffield JM, Williams LE, Woodward ND, Heckers S (2013) Schizophr Res 143(1): 185-91
    › Primary publication · 23178105 (PubMed) · PMC3540174 (PubMed Central)
  13. Thalamocortical dysconnectivity in schizophrenia. Woodward ND, Karbasforoushan H, Heckers S (2012) Am J Psychiatry 169(10): 1092-9
    › Primary publication · 23032387 (PubMed) · PMC3810300 (PubMed Central)
  14. Dopaminergic mechanisms of individual differences in human effort-based decision-making. Treadway MT, Buckholtz JW, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Kessler RM, Zald DH (2012) J Neurosci 32(18): 6170-6
    › Primary publication · 22553023 (PubMed) · PMC3391699 (PubMed Central)
  15. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial. Bobo WV, Woodward ND, Sim MY, Jayathilake K, Meltzer HY (2011) Schizophr Res 130(1-3): 106-13
    › Primary publication · 21641776 (PubMed)
  16. Functional resting-state networks are differentially affected in schizophrenia. Woodward ND, Rogers B, Heckers S (2011) Schizophr Res 130(1-3): 86-93
    › Primary publication · 21458238 (PubMed) · PMC3139756 (PubMed Central)
  17. Procedural learning in first episode schizophrenia investigated with functional magnetic resonance imaging. Purdon SE, Waldie B, Woodward ND, Wilman AH, Tibbo PG (2011) Neuropsychology 25(2): 147-58
    › Primary publication · 21381822 (PubMed)
  18. Human Ecstasy use is associated with increased cortical excitability: an fMRI study. Bauernfeind AL, Dietrich MS, Blackford JU, Charboneau EJ, Lillevig JG, Cannistraci CJ, Woodward ND, Cao A, Watkins T, Di Iorio CR, Cascio C, Salomon RM, Cowan RL (2011) Neuropsychopharmacology 36(6): 1127-41
    › Primary publication · 21326196 (PubMed) · PMC3079831 (PubMed Central)
  19. Correlation of individual differences in schizotypal personality traits with amphetamine-induced dopamine release in striatal and extrastriatal brain regions. Woodward ND, Cowan RL, Park S, Ansari MS, Baldwin RM, Li R, Doop M, Kessler RM, Zald DH (2011) Am J Psychiatry 168(4): 418-26
    › Primary publication · 21159728 (PubMed) · PMC3770457 (PubMed Central)
  20. Dopaminergic network differences in human impulsivity. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Kessler RM, Zald DH (2010) Science 329(5991): 532
    › Primary publication · 20671181 (PubMed) · PMC3161413 (PubMed Central)
  21. Eye-movement behavior reveals relational memory impairment in schizophrenia. Williams LE, Must A, Avery S, Woolard A, Woodward ND, Cohen NJ, Heckers S (2010) Biol Psychiatry 68(7): 617-24
    › Primary publication · 20655509 (PubMed) · PMC3184178 (PubMed Central)
  22. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Buckholtz JW, Treadway MT, Cowan RL, Woodward ND, Benning SD, Li R, Ansari MS, Baldwin RM, Schwartzman AN, Shelby ES, Smith CE, Cole D, Kessler RM, Zald DH (2010) Nat Neurosci 13(4): 419-21
    › Primary publication · 20228805 (PubMed) · PMC2916168 (PubMed Central)
  23. Intact associative learning in patients with schizophrenia: evidence from a Go/NoGo paradigm. Woolard AA, Kose S, Woodward ND, Verbruggen F, Logan GD, Heckers S (2010) Schizophr Res 122(1-3): 131-5
    › Primary publication · 20226631 (PubMed) · PMC2902634 (PubMed Central)
  24. The interrelationship of dopamine D2-like receptor availability in striatal and extrastriatal brain regions in healthy humans: a principal component analysis of [18F]fallypride binding. Zald DH, Woodward ND, Cowan RL, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Smith CE, Hakyemez H, Li R, Kessler RM (2010) Neuroimage 51(1): 53-62
    › Primary publication · 20149883 (PubMed) · PMC2862467 (PubMed Central)
  25. Cerebral morphology and dopamine D2/D3 receptor distribution in humans: a combined [18F]fallypride and voxel-based morphometry study. Woodward ND, Zald DH, Ding Z, Riccardi P, Ansari MS, Baldwin RM, Cowan RL, Li R, Kessler RM (2009) Neuroimage 46(1): 31-8
    › Primary publication · 19457373 (PubMed) · PMC2804466 (PubMed Central)
  26. MDMA (ecstasy) use is associated with reduced BOLD signal change during semantic recognition in abstinent human polydrug users: a preliminary fMRI study. Raj V, Liang HC, Woodward ND, Bauernfeind AL, Lee J, Dietrich MS, Park S, Cowan RL (2010) J Psychopharmacol 24(2): 187-201
    › Primary publication · 19304866 (PubMed) · PMC3198867 (PubMed Central)
  27. Prior MDMA (Ecstasy) use is associated with increased basal ganglia-thalamocortical circuit activation during motor task performance in humans: an fMRI study. Karageorgiou J, Dietrich MS, Charboneau EJ, Woodward ND, Blackford JU, Salomon RM, Cowan RL (2009) Neuroimage 46(3): 817-26
    › Primary publication · 19264142 (PubMed) · PMC2805435 (PubMed Central)
  28. Dopamine D2 receptor levels in striatum, thalamus, substantia nigra, limbic regions, and cortex in schizophrenic subjects. Kessler RM, Woodward ND, Riccardi P, Li R, Ansari MS, Anderson S, Dawant B, Zald D, Meltzer HY (2009) Biol Psychiatry 65(12): 1024-31
    › Primary publication · 19251247 (PubMed) · PMC2951678 (PubMed Central)
  29. Abnormal prefrontal cortical activity and connectivity during response selection in first episode psychosis, chronic schizophrenia, and unaffected siblings of individuals with schizophrenia. Woodward ND, Waldie B, Rogers B, Tibbo P, Seres P, Purdon SE (2009) Schizophr Res 109(1-3): 182-90
    › Primary publication · 19179050 (PubMed)
  30. Association of Sult4A1 SNPs with psychopathology and cognition in patients with schizophrenia or schizoaffective disorder. Meltzer HY, Brennan MD, Woodward ND, Jayathilake K (2008) Schizophr Res 106(2-3): 258-64
    › Primary publication · 18823757 (PubMed)
  31. An fMRI investigation of procedural learning in unaffected siblings of individuals with schizophrenia. Woodward ND, Tibbo P, Purdon SE (2007) Schizophr Res 94(1-3): 306-16
    › Primary publication · 17544630 (PubMed)
  32. COMT val108/158met genotype, cognitive function, and cognitive improvement with clozapine in schizophrenia. Woodward ND, Jayathilake K, Meltzer HY (2007) Schizophr Res 90(1-3): 86-96
    › Primary publication · 17123785 (PubMed)
  33. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2007) Schizophr Res 89(1-3): 211-24
    › Primary publication · 17059880 (PubMed)
  34. Procedural learning in schizophrenia investigated with functional magnetic resonance imaging. Zedkova L, Woodward ND, Harding I, Tibbo PG, Purdon SE (2006) Schizophr Res 88(1-3): 198-207
    › Primary publication · 16945506 (PubMed)
  35. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Woodward ND, Purdon SE, Meltzer HY, Zald DH (2005) Int J Neuropsychopharmacol 8(3): 457-72
    › Primary publication · 15784157 (PubMed)
  36. Procedural learning improvements after six weeks of clozapine treatment. Purdon SE, Woodward ND, Mintz A, LaBelle A (2002) Schizophr Res 53(1-2): 165-6
    › Primary publication · 11728847 (PubMed)
  37. Asymmetrical hand force persistence and neuroleptic treatment in schizophrenia. Purdon SE, Woodward ND, Flor-Henry P (2001) J Int Neuropsychol Soc 7(5): 606-14
    › Primary publication · 11459112 (PubMed)